These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 29579259

  • 1. High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey.
    Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H, ARPEC Project Group .
    J Pediatric Infect Dis Soc; 2019 May 11; 8(2):143-151. PubMed ID: 29579259
    [Abstract] [Full Text] [Related]

  • 2. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
    Gharbi M, Doerholt K, Vergnano S, Bielicki JA, Paulus S, Menson E, Riordan A, Lyall H, Patel SV, Bernatoniene J, Versporten A, Heginbothom M, Goossens H, Sharland M, ARPEC project Group members.
    BMJ Open; 2016 Nov 03; 6(11):e012675. PubMed ID: 27810974
    [Abstract] [Full Text] [Related]

  • 3. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.
    Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H, ARPEC project group.
    J Antimicrob Chemother; 2016 Apr 03; 71(4):1106-17. PubMed ID: 26747104
    [Abstract] [Full Text] [Related]

  • 4. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG, Mchedlishvili I, Javakhadze M, Versporten A, Goossens H, Phagava H, Pagava K.
    Georgian Med News; 2019 Apr 03; (292-293):72-75. PubMed ID: 31560667
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project.
    De Luca M, Donà D, Montagnani C, Lo Vecchio A, Romanengo M, Tagliabue C, Centenari C, D'Argenio P, Lundin R, Giaquinto C, Galli L, Guarino A, Esposito S, Sharland M, Versporten A, Goossens H, Nicolini G.
    PLoS One; 2016 Apr 03; 11(5):e0154662. PubMed ID: 27182926
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial prescription patterns in a tertiary-care pediatric unit in Thailand.
    Chautrakarn S, Anugulruengkitt S, Puthanakit T, Rattananupong T, Hiransuthikul N.
    Pediatr Int; 2020 Jun 03; 62(6):683-687. PubMed ID: 31957141
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, Jarlier V, Nathwani D, Goossens H, Global-PPS network.
    Lancet Glob Health; 2018 Jun 03; 6(6):e619-e629. PubMed ID: 29681513
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic usage in Chinese children: a point prevalence survey.
    Zhang JS, Liu G, Zhang WS, Shi HY, Lu G, Zhao CA, Li CC, Li YQ, Shao YN, Tian DY, Ding MJ, Li CY, Luo LJ, Dong XY, Jin P, Wang P, Zhu CM, Wang CQ, Zheng YJ, Deng JK, Sharland M, Hsia YF, Shen KL, Yang YH.
    World J Pediatr; 2018 Aug 03; 14(4):335-343. PubMed ID: 30062648
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial usage among hospitalized children in Latvia: a neonatal and pediatric antimicrobial point prevalence survey.
    Sviestina I, Mozgis D.
    Medicina (Kaunas); 2014 Aug 03; 50(3):175-81. PubMed ID: 25323546
    [Abstract] [Full Text] [Related]

  • 10. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries.
    Amadeo B, Zarb P, Muller A, Drapier N, Vankerckhoven V, Rogues AM, Davey P, Goossens H, ESAC III Hospital Care Subproject Group.
    J Antimicrob Chemother; 2010 Oct 03; 65(10):2247-52. PubMed ID: 20713405
    [Abstract] [Full Text] [Related]

  • 11. Point Prevalence Survey of Antimicrobial Prescribing in a Nigerian Hospital: Findings and Implications on Antimicrobial Resistance.
    Fowotade A, Fasuyi T, Aigbovo O, Versporten A, Adekanmbi O, Akinyemi O, Goossens H, Kehinde A, Oduyebo O.
    West Afr J Med; 2020 Oct 03; 37(3):216-220. PubMed ID: 32476113
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey.
    Abubakar U.
    BMC Infect Dis; 2020 Jan 30; 20(1):86. PubMed ID: 32000722
    [Abstract] [Full Text] [Related]

  • 13. A comparative analysis of prophylactic antimicrobial use in long-term care facilities in Ireland, 2013 and 2016.
    Tandan M, O'Connor R, Burns K, Murphy H, Hennessy S, Roche F, Donlon S, Cormican M, Vellinga A.
    Euro Surveill; 2019 Mar 30; 24(11):. PubMed ID: 30892182
    [Abstract] [Full Text] [Related]

  • 14. Surveillance of Antibiotic Consumption Point Prevalence Survey 2014: Antimicrobial Prescribing in Pediatrics Wards of 16 Iranian Hospitals.
    Fahimzad A, Eydian Z, Karimi A, Shiva F, Sayyahfar S, Kahbazi M, Rahbarimanesh A, Sedighi I, Arjmand R, Soleimani G, Sanaei Dashti A, Abdinia B, Mostafavi N, Nikfar R, Abedini M, Rezaei MS, Mohammadpour A, Hashemian H, Hidari H, Ghadiri K, Entezari Heravi R.
    Arch Iran Med; 2016 Mar 30; 19(3):204-9. PubMed ID: 26923893
    [Abstract] [Full Text] [Related]

  • 15. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey.
    Labi AK, Obeng-Nkrumah N, Nartey ET, Bjerrum S, Adu-Aryee NA, Ofori-Adjei YA, Yawson AE, Newman MJ.
    Antimicrob Resist Infect Control; 2018 Mar 30; 7():15. PubMed ID: 29423190
    [Abstract] [Full Text] [Related]

  • 16. Australia-wide Point Prevalence Survey of Antimicrobial Prescribing in Neonatal Units: How Much and How Good?
    Osowicki J, Gwee A, Noronha J, Britton PN, Isaacs D, Lai TB, Nourse C, Avent M, Moriarty P, Francis JR, Blyth CC, Cooper CM, Bryant PA, ANZPID-ASAP group (Australian and New Zealand Paediatric Infectious Diseases-Australasian Stewardship of Antimicrobials in Paediatrics).
    Pediatr Infect Dis J; 2015 Aug 30; 34(8):e185-90. PubMed ID: 25961896
    [Abstract] [Full Text] [Related]

  • 17. Identifying priorities to improve paediatric in-hospital antimicrobial use by cross-sectional evaluation of prevalence and appropriateness of prescription.
    Goycochea-Valdivia WA, Moreno-Ramos F, Paño-Pardo JR, Aracil-Santos FJ, Baquero-Artigao F, Del Rosal-Rabes T, Mellado-Peña MJ, Escosa-García L.
    Enferm Infecc Microbiol Clin; 2017 Nov 30; 35(9):556-562. PubMed ID: 28284685
    [Abstract] [Full Text] [Related]

  • 18. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.
    Zarb P, Goossens H.
    Drugs; 2011 Apr 16; 71(6):745-55. PubMed ID: 21504250
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial Use in a Swedish Pediatric Hospital: Results From Eight Point-prevalence Surveys Over a 15-Year Period (2003-2017).
    Luthander J, Bennet R, Nilsson A, Eriksson M.
    Pediatr Infect Dis J; 2019 Sep 16; 38(9):929-933. PubMed ID: 31220043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.